Differential Type I Interferon-dependent Transgene Silencing of Helper-dependent Adenoviral vs. Adeno-associated Viral Vectors In Vivo
Authors:
Open Access
- 1 April 2013
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 21 (4) , 796-805
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia BNew England Journal of Medicine, 2011
- RETRACTED: Activation of the NF-κB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapyProceedings of the National Academy of Sciences, 2011
- Species Differences in the Pharmacology and Toxicology of PEGylated Helper-Dependent AdenovirusMolecular Pharmaceutics, 2010
- Large-Scale Production of High-Quality Helper-Dependent Adenoviral Vectors Using Adherent Cells in Cell FactoriesHuman Gene Therapy, 2010
- Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligandsNature Immunology, 2009
- RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I PathwayCell, 2009
- Virus Binding to a Plasma Membrane Receptor Triggers Interleukin-1α-Mediated Proinflammatory Macrophage Response In VivoImmunity, 2009
- ICP0 Inhibits the Decrease of HSV Amplicon-mediated Transgene ExpressionMolecular Therapy, 2009
- Efficient, Long-term Hepatic Gene Transfer Using Clinically Relevant HDAd Doses by Balloon Occlusion Catheter Delivery in Nonhuman PrimatesMolecular Therapy, 2009
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008